BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2015
View Archived Issues
New data presented on the use of [18F]AV14151 as a tau PET tracer
Read More
Rigel Pharmaceuticals reviews development pipeline
Read More
Phase II data on the coadministration of VT-122 and sorafenib to HCC patients reported
Read More
Famitinib improves progression-free survival in CRC patients
Read More
Pilot study investigates imaging markers to guide PBT-2 development
Read More
Final results of phase I/II study of ISIS-183750 plus irinotecan
Read More
Johnson & Johnson reviews progress of fourth quarter 2014
Read More
Trovagene and Genomac Research Institute to collaborate on cancer drug resistance prediction trials
Read More
Endonovo Therapeutics agrees on equity investment
Read More
Athersys and Cell Therapy Catapult receive stem cell therapy grants for acute respiratory condition
Read More
Japan Tobacco divulges PDHK inhibitors
Read More
Forendo Pharma reports development of 17beta-HSD1 inhibitors
Read More
Merck KGaA prepares positive allosteric modulators for infertility
Read More
Sichuan Haisco Pharmaceutical presents SGLT2 inhibitors for diabetes
Read More
Alligator Bioscience discloses polypeptides binding to CTLA-4 for cancer
Read More
FDA grants orphan drug status to intracerebral hemorrhage treatment
Read More
APR-246 receives European orphan drug designation
Read More
Human abuse liability study of Egalet meets primary endpoint
Read More
GSK ships Ebola vaccine candidate to Liberia for phase III trial
Read More
FDA clears IND for phase I study of ADXS-HER2
Read More
FDA advisory committee recommends approval of Cresemba
Read More
Heptares and AstraZeneca advance drug discovery collaboration
Read More
Alexza Pharmaceuticals initiates phase II trial of inhaled alprazolam in epilepsy
Read More
Sigma-Aldrich and VIB form alliance to supply translational research tools and technologies
Read More
Ultimovacs completes share issue to fund development of cancer vaccine UV-1
Read More
CytRx reports results from phase IIb trial of aldoxorubicin in soft tissue sarcoma
Read More
CHMP issues positive opinion for Prevenar 13 for prevention of pneumococcal pneumonia
Read More